1. Home
  2. LUNG vs HYI Comparison

LUNG vs HYI Comparison

Compare LUNG & HYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • HYI
  • Stock Information
  • Founded
  • LUNG 1995
  • HYI 2010
  • Country
  • LUNG United States
  • HYI United States
  • Employees
  • LUNG N/A
  • HYI N/A
  • Industry
  • LUNG Industrial Specialties
  • HYI Investment Managers
  • Sector
  • LUNG Health Care
  • HYI Finance
  • Exchange
  • LUNG Nasdaq
  • HYI Nasdaq
  • Market Cap
  • LUNG 299.3M
  • HYI 266.3M
  • IPO Year
  • LUNG 2020
  • HYI N/A
  • Fundamental
  • Price
  • LUNG $7.77
  • HYI $11.97
  • Analyst Decision
  • LUNG Strong Buy
  • HYI
  • Analyst Count
  • LUNG 7
  • HYI 0
  • Target Price
  • LUNG $12.64
  • HYI N/A
  • AVG Volume (30 Days)
  • LUNG 464.2K
  • HYI 50.6K
  • Earning Date
  • LUNG 04-30-2025
  • HYI 01-01-0001
  • Dividend Yield
  • LUNG N/A
  • HYI 9.59%
  • EPS Growth
  • LUNG N/A
  • HYI N/A
  • EPS
  • LUNG N/A
  • HYI N/A
  • Revenue
  • LUNG $83,789,000.00
  • HYI N/A
  • Revenue This Year
  • LUNG $17.96
  • HYI N/A
  • Revenue Next Year
  • LUNG $18.35
  • HYI N/A
  • P/E Ratio
  • LUNG N/A
  • HYI N/A
  • Revenue Growth
  • LUNG 22.01
  • HYI N/A
  • 52 Week Low
  • LUNG $5.46
  • HYI $10.99
  • 52 Week High
  • LUNG $10.01
  • HYI $12.24
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 52.56
  • HYI 50.06
  • Support Level
  • LUNG $7.65
  • HYI $11.79
  • Resistance Level
  • LUNG $8.12
  • HYI $11.86
  • Average True Range (ATR)
  • LUNG 0.49
  • HYI 0.08
  • MACD
  • LUNG -0.06
  • HYI -0.00
  • Stochastic Oscillator
  • LUNG 45.71
  • HYI 52.94

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About HYI Western Asset High Yield Defined Opportunity Fund Inc.

Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. It invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.

Share on Social Networks: